U.S. Airlines Stock News

EPR Properties dividend announcement and what it means for investors EPR Properties (EPR) has reaffirmed its monthly dividend policy, with the Board of Trustees declaring a cash dividend of $0.31 per share, annualized at $3.72, payable on September 15, 2026. See our latest analysis for EPR Properties. At a share price of $60.37, EPR Properties has a year to date share price return of 18.93%, while its 1 year total shareholder return of 20.43% sits alongside 3 and 5 year total shareholder...

Alarm.com Holdings, Inc. reported past second-quarter 2026 results showing revenue rising to US$277.73 million from US$254.31 million a year earlier, while net income fell to US$24.25 million from US$34.55 million and diluted EPS from continuing operations declined to US$0.48 from US$0.63. Despite lower profitability, management raised its full-year 2026 total revenue outlook to between US$1.08 billion and US$1.09 billion, including US$325.0 million to US$335.0 million of hardware and other...

In August 2026, Portland General Electric submitted proposed revisions to its Open Access Transmission Tariff to the Federal Energy Regulatory Commission to support its previously approved participation in the CAISO Extended Day-Ahead Market from October 2026, including a new template agreement for Load Serving Entities in its balancing authority area. A distinctive element of the filing is Portland General’s plan to act as Scheduling Coordinator for participating customers while waiving...

Bond markets are under pressure, inflation concerns are back in focus and central banks are keeping investors guessing. That mix is shaking up how cash, money market funds and short-duration fixed income are used inside portfolios. Some stocks linked to these products may gain from this reset in yields and risk pricing. This article looks at 3 stocks from our screener that appear particularly exposed to the latest news. The stocks highlighted below are only a sample, and the full screen...

In August 2026, Everus Construction Group, Inc. (NYSE: ECG) highlighted its active acquisition pipeline, emphasizing recent deals for SE&M and the pending Epsilon acquisition to expand its geographic footprint, diversify its business mix and deepen its presence across electrical, mechanical and transmission and distribution (T&D) segments. At the same time, analysts have become more optimistic about Everus Construction Group’s earnings outlook, with upward estimate revisions suggesting that...

In early August 2026, Haemonetics Corporation reported past first-quarter results with sales rising to US$339.38 million while net income eased to US$33.01 million, and simultaneously filed a US$391.25 million shelf registration for 4,680,000 shares tied to an ESOP-related common stock offering. The combination of modest earnings pressure alongside plans to access additional equity capital highlights how Haemonetics is balancing near-term performance with funding flexibility for future...

Elanco Animal Health (ELAN) is back in focus after second quarter 2026 results showed higher sales and net income versus a year earlier, along with slightly raised full year revenue guidance. See our latest analysis for Elanco Animal Health. The stronger second quarter earnings and slightly higher full year revenue guidance appear to be feeding into Elanco Animal Health's recent share price trend. The company has recorded a 7 day share price return of 4.0% and a 90 day share price return of...

German American Bancorp (GABC) is back in focus after recent commentary highlighted its record of regular dividend increases, a 33% payout ratio, and management expectations for solid earnings in the coming fiscal year. See our latest analysis for German American Bancorp. The recent focus on dividend growth comes alongside a strong period for German American Bancorp's stock, with a 30 day share price return of 5.12% and a 90 day share price return of 17.43%. Over the longer term, the picture...

In August 2026, NewAmsterdam Pharma reported second-quarter 2026 results showing sales of US$3.7 million versus US$19.15 million a year earlier, alongside a wider net loss of US$64.14 million compared with US$17.36 million. Over the first half of 2026, the company’s sales fell to US$6.74 million while its net loss roughly doubled to US$112.58 million, highlighting rising costs against shrinking revenue. Next, we examine how this sharp revenue drop and widening losses shape NewAmsterdam...

Kemper (KMPR) stock is back in focus after second quarter results showed a net loss of $464.8 million, driven largely by a $460 million goodwill impairment, while the company kept its regular $0.32 dividend. See our latest analysis for Kemper. At a share price of $26.21, Kemper has seen its short term momentum soften, with a 30 day share price return of 6.46% and a 90 day return of an 11.15% decline. The 1 year total shareholder return of a 49.9% decline and 5 year total shareholder return of...

LyondellBasell Industries recently declared a US$0.69 per-share dividend, paid on August 31, 2026, to shareholders of record as of August 24, 2026. This dividend decision comes shortly after a stronger Q2 2026, when supply disruptions in the Middle East lifted margins and improved quarterly performance. Now we will examine how Q2’s margin boost from Middle East supply disruptions shapes LyondellBasell’s broader investment narrative and risks. Find 50 companies with promising cash flow...

Valvoline (VVV) has reshaped its balance sheet through new senior notes due 2034 and an amendment to its revolving credit facility. This refinancing move focuses on debt maturities, liquidity, and access to capital. See our latest analysis for Valvoline. Over the past year, Valvoline’s share price has moved sharply at times, with a 16.49% year to date share price return contrasted by a 14.03% decline in total shareholder return over 12 months. This suggests momentum has recently faded despite...

In August 2026, Innodata Inc. reported second‑quarter 2026 results showing sales of US$92.14 million and net income of US$14.41 million, reaffirmed its full‑year 2026 revenue growth guidance of at least 40% year‑over‑year, and announced a leadership transition with President and Chief Revenue Officer Rahul Singhal set to become CEO as of September 30, 2026. Alongside these results, Innodata refreshed its capital options by withdrawing a prior US$50 million shelf registration, filing a new...

Tennant Company has reported past second-quarter 2026 results showing sales of US$324.0 million versus US$318.6 million a year earlier, while net income fell to US$7.6 million from US$20.2 million, and first-half earnings per share declined despite slightly higher sales. At the same time, Tennant raised its full-year 2026 outlook, guiding to higher net sales of US$1.27 billion–US$1.31 billion and diluted earnings per share of US$2.15–US$2.80, highlighting management’s confidence in a...

Fresh IRS rules on untaxed overtime are about to put more money into millions of paychecks, and that extra cash has to go somewhere. For investors, this shift in disposable income could quietly reshape which U.S. consumer discretionary stocks benefit as everyday workers adjust their spending. This article breaks down the story and highlights three stocks from the screener that appear closely tied to this overtime tax catalyst. The three stocks below are only a starting sample from this...

Clear Channel Outdoor Holdings, Inc. has reported its past second-quarter 2026 results, with sales rising to US$438.04 million from US$402.81 million a year earlier, but shifting from net income of US$9.52 million to a net loss of US$5.32 million. Despite higher revenue for both the quarter and first half of 2026, the company moved from earnings per share to losses per share, highlighting pressure on profitability. We’ll now examine how the swing from profit to loss, despite higher sales,...

BridgeBio Pharma, Inc. recently completed a US$390.0 million follow-on equity offering at US$78 per share, while reporting second-quarter 2026 revenue of US$243.68 million and a net loss of US$152.22 million, alongside updated results for the six months to June 30, 2026. At the same time, BridgeBio highlighted extensive new clinical and real-world data for Attruby (acoramidis) and advanced its rare-disease pipeline with regulatory progress for BBP-418 and encaleret, underlining how fresh...

In early August 2026, ICF International reported second-quarter 2026 results showing relatively flat sales at US$474.5 million but higher net income of US$26.95 million year-on-year, reaffirmed its full-year 2026 revenue and GAAP EPS guidance backed by a largely secured backlog, maintained its quarterly US$0.14 dividend, and detailed completion of a multi-year share repurchase program. The company also highlighted a new US$35 million energy efficiency contract from Entergy Louisiana,...

New York Times (NYT) is back in focus after reporting second quarter and first half 2026 results that showed higher revenue, net income and earnings per share compared with the same periods a year earlier. See our latest analysis for New York Times. Despite the improved second quarter results and ongoing share repurchases, New York Times’ recent 30 day share price return is down 14.3% and the 90 day share price return is down 12.46%, although the 1 year total shareholder return of 10.3% and 3...

Escalating Canada–US trade friction and fresh US tariffs on about US$20b of Canadian goods are reshaping where construction and building materials flow, and who gets paid. For investors, that shift could redirect demand toward U.S. stocks tied to cement, aggregates, lumber and related products, creating both potential openings and pitfalls. This article walks through three U.S. Domestic Construction & Building Materials Beneficiaries of Canada–U.S. Tariff Escalation screener stocks that are...

Why Stoke Therapeutics Stock Is Back In Focus After A Key Trial Milestone Stoke Therapeutics (STOK) is drawing fresh attention after its Phase III EMPEROR trial for Dravet syndrome exceeded its 150 patient enrollment target, reaching 162 participants with no discontinuations reported. See our latest analysis for Stoke Therapeutics. At a share price of $32.14, Stoke Therapeutics has seen a 10.64% 1 month share price return and a 73.82% 1 year total shareholder return. These figures suggest...

Florida’s surprise primary result, with democratic socialist Angie Nixon advancing in the Senate race, has pushed healthcare policy risk back into the spotlight. For investors, the stakes around Medicare, Medicaid and ACA funding now feel more tangible. This can quickly reprice expectations for U.S. Healthcare and Managed Care stocks. This article walks through three stocks exposed to that shifting policy debate and explains why each might matter for your portfolio watchlist. The stocks...

Biglari Holdings (BH.A) reported second quarter 2026 results that showed higher sales and revenue, while quarterly net income and earnings per share from continuing operations were lower than a year earlier. See our latest analysis for Biglari Holdings. The mixed earnings picture comes as Biglari Holdings shares trade at US$1,962.51, with a 90 day share price return of 42.76% and a 1 year total shareholder return of 28.27%. This points to strong recent momentum on top of longer term gains. If...

J.M. Smucker recently unveiled the first major refresh of its Jif branding in more than 30 years, modernizing the tri-color logo, cleaning up typography, and updating packaging imagery to highlight new snack ideas and usage occasions. The revamped look, paired with innovations like squeezable formats, new flavored and “Simply” spreads, and the renaming of Jif To Go to Jif Dippers, underscores how the company is reshaping a core legacy brand around evolving consumer preferences for quick,...